SPOTLIGHT -
Non-contact ultra-widefield proves useful
Carl Zeiss Meditec AG announces completed acquisition of Dutch Ophthalmic Research Center
Zeiss has secured regulatory approvals to acquire DORC and will shift focus to integration implementation
Hemorrhagic unilateral retinopathy: No proven aetiology for rare condition
Multimodal imaging and a systemic work-up failed to identify any underlying disorder for the hemorrhages
Exonate shares results from Phase Ib/IIa trial of EXN407 eye drops for DR and DME
In addition to the primary safety and tolerability endpoints, the study also saw signals of biological response from EXN407
COPHy 2024: Intraocular inflammation as a risk factor resulting from use of anti-complement agents for GA
Good news for patients: use of anti-complement therapies have caused the growth rate of GA lesions to decrease
Kiora publishes results from Phase 1 study demonstrating safety, tolerability and efficacy of KIO-101
Kiora also stated a Phase 2 trial of KIO-104 is expected to begin later this year
The “fourth dimension” of home monitoring
A longitudinal, AI-based approach to fluid quantification
